ID-5184 Wonca Abstracts supplement L-Z 13-10-23 - Flipbook - Page 42
WONCA 2023 Supplement 2: WONCA 2023 abstracts (L–Z)
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Cost-effectiveness analysis of digital therapeutics for
home-based cardiac rehabilitation for patients with chronic
heart failure: Model development and data analysis
博士 Tianyi Liu1, Wenhong Zhang1,2, E/Prof Yiyang Zhan4, A/Prof Jian Jia3, Silei Chen1, Wen Chen2
1
School of Business, Nanjing University, 2National Institute of Healthcare Data Science, Nanjing
University, 3Departments of General Practice, The First Affiliated Hospital of Nanjing Medical University,
4
Departments of Geriatric Practice, The First Affiliated Hospital of Nanjing Medical University
Background
In recent years, numerous guidelines and expert consensus have recommended the inclusion of digital
technologies and products in cardiac rehabilitation.
Objective
This study aimed to conduct an early technology assessment of digital therapeutics. Based on the
evaluation methods and models of health economics, we analyse the potential cost effectiveness of
digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure from
the perspective of healthcare decision makers so as to provide a basis and reference for application
and the promotion of digital therapeutics.
Methods
Markov models were constructed to simulate the outcomes of digital therapeutics for home-based
cardiac rehabilitation (DT group) compared to conventional home-based cardiac rehabilitation (UC
group) in patients with chronic heart failure. Model input parameters were clinical indicators and
cost data. The outcome indicators were quality-adjusted life years (QALYs) and incremental costeffectiveness ratios (ICERs). The robustness of the evaluation methods and results was tested by
sensitivity analyses. Clinical indicators, cost data and health utility values were obtained from realworld data, including clinical study data, published literature and public website information.
Results
The Markov model simulated a time span of 10 years with the cycle set at one month, for a total of 120
cycles. The results showed that the per-capita cost of the UC group was 38,442.11 RMB/year, with a
QALY of 0.7196 per person per year. The per-capita cost of the DT group was 42,300.26 RMB/year,
with a QALY of 0.81687 per person per year. The ICER per person was 39,663.5 RMB/QALY each
year, which was below the willingness-to-pay threshold of 80,976 RMB.
Conclusions
Digital therapeutics for home-based cardiac rehabilitation is an extremely cost-effective rehabilitation
option compared to conventional home-based cardiac rehabilitation. From the perspective of
healthcare decision makers, digital therapeutics for home-based cardiac rehabilitation is
potentially valuable.
40